Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Claritas Pharmaceuticals Inc (CLAS.VN)

Claritas Pharmaceuticals Inc (CLAS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Claritas Announces Approval from OTC to Up-List to OTCQB Globe Newswire - Thu Apr 7, 2022

SAN FRANCISCO, CA and TORONTO, ON, April 07, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the...

CLAS.VN : 0.025 (-16.67%)
OTC.VN : 0.295 (-1.67%)
CLAS : 10.17 (+0.20%)
CLAZF : 0.0001 (unch)
Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107 Globe Newswire - Tue Apr 5, 2022

SAN FRANCISCO, CA and TORONTO, ON, April 05, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the...

CLAS.VN : 0.025 (-16.67%)
OTC.VN : 0.295 (-1.67%)
CLAS : 10.17 (+0.20%)
CLAZF : 0.0001 (unch)
Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing Globe Newswire - Tue Feb 22, 2022

SAN FRANCISCO, CA and TORONTO, ON , Feb. 22, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or...

OTC.VN : 0.295 (-1.67%)
CLAS.VN : 0.025 (-16.67%)
KALTF : 0.1100 (unch)
Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022 Globe Newswire - Wed Feb 9, 2022

Ethics Committee Approval is Final Step Prior to Enrollment of Claritas’ Phase 1 Clinical Study of R-107...

OTC.VN : 0.295 (-1.67%)
CLAS.VN : 0.025 (-16.67%)
KALTF : 0.1100 (unch)
Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners Globe Newswire - Wed Jan 26, 2022

SAN FRANCISCO, CA and TORONTO, ON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or...

OTC.VN : 0.295 (-1.67%)
CLAS.VN : 0.025 (-16.67%)
KALTF : 0.1100 (unch)
Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns Globe Newswire - Mon Jan 17, 2022

SAN FRANCISCO, CA and TORONTO, ON, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: KLY and OTC: KALTF) (the "Company" or...

CLAS.VN : 0.025 (-16.67%)
OTC.VN : 0.295 (-1.67%)
KLY.VN : 0.045 (unch)
KALTF : 0.1100 (unch)
Claritas Announces New Registered and Records Office Address, Confirms its Management and Directors and Announces Terms of Initial Tranche of Equity Financing with Alumina Partners Globe Newswire - Mon Jan 17, 2022

SAN FRANCISCO, CA and TORONTO, ON, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or...

OTC.VN : 0.295 (-1.67%)
CLAS.VN : 0.025 (-16.67%)
KALTF : 0.1100 (unch)
Claritas Secures $5 Million Equity Financing Facility with Alumina Partners (Ontario) Ltd. Globe Newswire - Wed Jan 12, 2022

SAN FRANCISCO, CA and TORONTO, ON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or...

OTC.VN : 0.295 (-1.67%)
CLAS.VN : 0.025 (-16.67%)
KALTF : 0.1100 (unch)
Claritas to Develop R-107 for Treatment of PPHN, a Potentially Fatal Pulmonary Disorder in Newborns Globe Newswire - Wed Dec 22, 2021

SAN FRANCISCO, CA, and TORONTO, ON, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or...

OTC.VN : 0.295 (-1.67%)
CLAS.VN : 0.025 (-16.67%)
KALTF : 0.1100 (unch)
Claritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Disease Globe Newswire - Tue Dec 21, 2021

Data in Animal Model of PAH Demonstrate Ability of R-107 to Reverse Progression of the Disease...

OTC.VN : 0.295 (-1.67%)
CLAS.VN : 0.025 (-16.67%)
KALTF : 0.1100 (unch)

Barchart Exclusives

Is Palo Alto Stock a Buy Right Now? Barchart - Sat May 25, 11:45AM CDT
Cybersecurity stock Palo Alto got punished after lowering the upper rail of its billings guidance, but analysts say the sell-off was an overreaction. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot